IFN-CONTAINING HEPATIC FUNCTION-IMPROVING AGENT ADMINISTERED BASED ON HAPLO TYPE ANALYSIS OF SURFACE ANTIGEN-PRESENTING MOLECULE

Title:

IFN-CONTAINING HEPATIC FUNCTION-IMPROVING AGENT ADMINISTERED BASED ON HAPLO TYPE ANALYSIS OF SURFACE ANTIGEN-PRESENTING MOLECULE

Document Type and Number:

Japanese Patent JP2002128692

Kind Code:

A

Abstract:

To obtain a hepatic function-improving agent for viral hepatitis patients.

This hepatic function-improving agent can improve the hepatic function in a high frequency even for a hyper viremia patient by selecting viral hepatitis patients holding HLA-class IA24 or A26 as a surface antigen- exhibiting molecule and above all selecting patients exhibiting a hepatic functional value (ALT value in blood) of within 4 fold value of the upper limit of its normal value and administering IFN to them.

Inventors:

NISHIGUCHI SHUHEI
TANAKA MOTOHARU
KANESHIRO SOJI
TAKEDA TADASHI
TOFUJI NAOKI

Application Number:

JP2000320833A

Publication Date:

May 09, 2002

Filing Date:

October 20, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NISHIGUCHI SHUHEI
SUMITOMO PHARMA

International Classes:

A61K38/21; A61P1/16; A61P31/12; (IPC1-7): A61K38/21; A61P1/16; A61P31/12

Attorney, Agent or Firm:

Aoyama Ryo (1 person outside)

Previous Patent: SERICIN-CONTAINING RAW MATERIAL, METHOD FOR PRODUCING THE SAME AND METHOD FOR USING THE SAME

Next Patent: THERAPEUTIC AGENT FOR CHRONIC HEPATITIS C BY ANALYSIS OF LMP7